NCT01521650

Brief Summary

Longer surgical procedures require intubation and there is a potential risk of contaminating the lower airways with pathogenic bacteria from the mouth and oropharynx. Healthy people seldom have pathogenic bacteria originating from the gastro-intestinal canal but those do occur among patients, both in those not so sick and patients with more severe problems. For ICU patients we have seen a reduction of emerging enteric bacteria in patients given oral care with probiotics and this is a pilot study to explore the possibility of the same kind of positive effects in patients due for longer (more than 4 hours of anesthesia) procedures. Randomisation

  • No prophylaxis
  • Preparation with a probiotic suspension before intubation. Cultures
  • oropharynx
  • before treatment
  • after intubation
  • before extubation
  • day 1 postoperatively
  • tracheal secretions
  • after intubation
  • before extubation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

January 26, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 31, 2012

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

March 10, 2021

Status Verified

March 1, 2021

Enrollment Period

7.2 years

First QC Date

January 26, 2012

Last Update Submit

March 8, 2021

Conditions

Keywords

ProbioticsAnaesthesiaIntubationPathogenic bacteria

Outcome Measures

Primary Outcomes (1)

  • Differences in pathogenic bacteria in the oropharynx and lower airways

    Emerging and resident bacteria will be compared for the cultures taken in the oropharynx and from tracheal secretions in conection with anaestesia and a surgical intervention

    During hospitalization, up to 4 weeks

Secondary Outcomes (4)

  • White blood cells

    During hospitalization, up to 4 weeks

  • CRP

    During hospitalization, up to 4 weeks

  • Pneumonia

    Up till 7 days postoperatively

  • Length of hospital stay

    time to discharged from hospital or patients death

Study Arms (2)

Probiotics

EXPERIMENTAL

Patients will gurgle and swallow a mixture of probiotic bacteria

Dietary Supplement: Probiotics

Control

NO INTERVENTION

No intervention. What has been the standard procedure so far

Interventions

ProbioticsDIETARY_SUPPLEMENT

Patients will gurgle and swallow a mixture of probiotic bacteria

Also known as: Lactobacillus plantarum 299, Lactobacillus plantarum 299v
Probiotics

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients
  • Planned interventions
  • Anaesthesia \> 4 hours and requiring intubation

You may not qualify if:

  • Ulcers in the mouth, oropharynx, oesophagus and stomach
  • Current infections in the airways
  • Known immuno deficiences
  • Emergency cases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lund University Hospital

Lund, SE-22185, Sweden

Location

Related Publications (2)

  • Stjernquist-Desatnik A, Warfving H, Johansson ML. Persistence of Lactobacillus plantarum DSM 9843 on human tonsillar surface after oral administration in fermented oatmeal gruel. A pilot study. Acta Otolaryngol Suppl. 2000;543:215-9. doi: 10.1080/000164800454422.

    PMID: 10909023BACKGROUND
  • Klarin B, Molin G, Jeppsson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit Care. 2008;12(6):R136. doi: 10.1186/cc7109. Epub 2008 Nov 6.

    PMID: 18990201BACKGROUND

MeSH Terms

Interventions

Probiotics

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Bengt klarin, MD PhD

    Lund University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD Consultant

Study Record Dates

First Submitted

January 26, 2012

First Posted

January 31, 2012

Study Start

January 1, 2012

Primary Completion

March 1, 2019

Study Completion

July 1, 2020

Last Updated

March 10, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will share

Results are intended to be published in a scientific journal

Locations